GlassScriptPhysician profile
Joseph B Shrager
NPI 1619904521
$56,319.51
in general payments reported to CMS, 2019-2025
12 companies · $2,653 in 2025
The $2,653 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $14K · 2021: $2,500 · 2022: $2,067 · 2023: $2,881 · 2024: $3,041 · 2025: $2,653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,474 · Food and Beverage: $986 · Travel and Lodging: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,474.00 |
| Food and Beverage | $985.50 |
| Travel and Lodging | $115.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $29,249.66 | 2019 | |
| Bard Peripheral Vascular, INC. | $19,799.87 | 2020-2024 | |
| Lungpacer Medical USA INC | $2,500.00 | 2025 | Aeropace Neurostimulation Console |
| Medela Ag | $1,500.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $1,453.99 | 2022-2024 | Imfinzi |
| Medtronic, INC. | $934.30 | 2022-2025 | Signia |
| Intuitive Surgical, INC. | $493.27 | 2019-2023 | Da Vinci Surgical System |
| Covidien LP | $272.70 | 2019-2020 | |
| Genentech USA, INC. | $86.70 | 2024 | Alecensa |
| Bard Access Systems, INC. | $29.02 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Shrager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.